Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Lee

Vascular & Interventional Radiology Los Angeles, CA Medical Doctor

NPI 1215189550 CMS profile 54369

757 Westwood Plz Ste 2125B, Los Angeles, CA 90095

Open in the dashboard

General payments

$1,364,172

1,150 records reported · program years 2019–2025

Research payments

$24,118

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$357,277 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Edward Lee of Los Angeles, CA is reported in the CMS Open Payments database as having received $1,364,172 across 1,150 general payments and $24,118 in research payments paid to them. Separately, studies naming them as principal investigator received $357,277 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $311,760 202
2024 General $341,335 279
2023 General $221,895 167
2022 General $234,035 265
2022 Research $15,250 7
2021 General $137,803 122
2020 General $35,748 42
2019 General $81,597 73
2019 Research $8,868 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Lee
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Edward Lee were reported at $311,760. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Edward Lee Vascular & Interventional Radiology median Middle half National median
2019 $81,597 $422 $125–$1,555 $163
2020 $35,748 $200 $68–$652 $114
2021 $137,803 $280 $99–$866 $132
2022 $234,035 $433 $137–$1,497 $149
2023 $221,895 $506 $152–$2,019 $160
2024 $341,335 $556 $175–$1,930 $164
2025 $311,760 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sirtex Medical Inc $659,629 392 payments
  2. Terumo Medical Corporation $468,116 511 payments
  3. W. L. Gore & Associates, Inc. $119,574 41 payments
  4. Siemens Medical Solutions USA, Inc. $34,908 39 payments
  5. Boston Scientific Corporation $23,246 44 payments
  6. Cook Incorporated $18,560 4 payments
  7. MicroVention, Inc. $11,100 3 payments
  8. Bard Peripheral Vascular, Inc. $8,587 38 payments
  9. Philips Electronics North America Corporation $5,257 7 payments
  10. Varian Medical Systems, Inc. $5,175 4 payments
  11. Other $10,019 67 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $650,622 248 payments
  2. Consulting Fee $518,383 183 payments
  3. Travel and Lodging $128,797 320 payments
  4. Honoraria $35,400 6 payments
  5. Food and Beverage $22,125 389 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $8,800 3 payments
  7. Education $45 1 payment
Products named General payments · program years 2019–2025
  1. SIR-Spheres Microspheres $659,629 392 payments
  2. Azur CX Detachable $403,794 449 payments
  3. NAVICROSS Vascular Access $65,576 41 payments
  4. VIATORR Endoprosthesis $53,539 14 payments
  5. Navicross Vascular Access $38,275 19 payments
  6. VIATORR TIPS Endoprosthesis $35,150 7 payments
  7. GlideWire $23,750 13 payments
  8. TR Band $23,163 16 payments
  9. Glidesheath $22,350 12 payments
  10. ONCOZENE $18,000 1 payment
  11. Other $176,785 297 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. MicroVention, Inc. $24,118 10 payments

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$67,411

Medicare's payments for the services billed

Medicare patients

114

Average age 67

Services billed

622

52 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 62%
Diabetes 61%
Arthritis 47%
Ischemic heart disease 39%
Heart failure 37%
Depression 32%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,160 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record